Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444821 · ClinicalTrials.gov registry record · NA
The (PIVOTAL) Study
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 728
- Enrollment target
NCT00444821 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 728 participants.
The verdict
NCT00444821, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 728 participants
- Enrollment target
Study Summary
The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
Interventions
- DEVICE AneuRx AAA stent graft / Talent AAA stent graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 728 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444821
The ClinicalTrials.gov registry entry for NCT00444821 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 728 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AneuRx AAA stent graft / Talent AAA stent graft is the first listed.
NCT00444821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444821 about?
NCT00444821 is a clinical study titled "The (PIVOTAL) Study". The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
What is the current status of trial NCT00444821?
This trial is currently terminated. It is a NA study. The enrollment target is 728 participants. The study started on 2005-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00444821?
The interventions under investigation include: AneuRx AAA stent graft / Talent AAA stent graft (DEVICE).
Who is sponsoring clinical trial NCT00444821?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.